AI Research Tool for GLP-1

Make confident GLP‑1 formulation and delivery innovation calls

Discover next-gen formulations, novel delivery mechanisms, and safety insights backed by real research with AI-powered research intelligence designed specifically for GLP-1 R&D.

Future-proof your GLP-1 innovation
with AI-powered research

85% Faster

Drug Discovery Research

3x More Confident

Formulation Decisions

40% Reduction

In Duplicated Research Efforts

Find What's Next

Discover emerging GLP-1 therapies, novel drug delivery systems, and competitor innovations before they hit the market.

Validate Instantly

Quickly assess new GLP-1 formulations, therapeutic targets, and delivery mechanisms with AI-driven insights from patents and research papers.

Optimize R&D Costs

Reduce R&D costs by avoiding duplicated research and ensure your GLP-1 development efforts are streamlined from day one.

More Research, Less Busywork, Higher Impact

Centralize Knowledge Base

Explore GLP-1 formulations by delivery route and stability profiles

Slate organizes research on injectable, oral, and implantable GLP-1 formulations based on pH tolerance, enzymatic degradation, and half-life extension strategies, enabling faster shortlisting.

Ingredient Discovery

Find GLP-1 friendly ingredients for foods, snacks and beverages

Discover functional ingredients, natural stimulants, bioactives, product formulations, and dietary approaches targeting GLP-1 pathways before your competitors do.

Formulation Scouting

Identify alternative carriers, stabilizers, and delivery technologies backed by real research

Slate surfaces functional alternatives to PEGs, lipids, or microspheres used in GLP-1 delivery based on validated data from other biologic formulations or adjacent therapeutic areas.

Claim Benchmarking

Validate therapeutic and safety claims with scientific proof

Side-by-side comparisons of efficacy and safety data in patents and clinical studies to support claims like “improved glucose control” or “reduced cardiovascular risk” for GLP-1 therapeutics.

Competitive Intelligence

Benchmark your GLP-1 pipeline against the market leaders

Compare your R&D roadmap with 100+ active GLP‑1 projects and see who’s leading in dual or tri-agonist development, what trials are in which phase, and where your opportunity lies.

Formulation Optimization

Find interactions between peptides, excipients, and delivery systems for long‑acting formulations

Uncover co-cited stabilizers, absorption enhancers, and polymer systems that influence bioavailability and pharmacokinetics in GLP-1 analog delivery that may have superior performance or novel applications.

Cross-Industry Solution

Repurpose controlled release or targeting methods from adjacent domains and avoid redundancy

Slate connects you to relevant research outside your core field where innovation often hides, and lets you explore ideas from oncology, reproductive health, or CNS drugs to solve formulation challenges in GLP-1.

Trend Forecasting

Track emerging GLP-1 trends and technologies before they make headlines

Identify tech gaps and white spaces others haven’t yet noticed by tracking shifts in volume and co-authorship around GLP-1 landscape like GLP-1/GIP/glucagon dual or triple agonists, and oral peptide delivery tech.

Before

6 weeks to analyze 100+ patents and research papers, material scouting, and compliance checks, relying on manual searches across multiple sources.

96X

Faster insights, delivering in:

With Slate

1 day to uncover 6 emerging materials with industry use cases.

3 hours to map 10 competitor innovations across patents & market activity.

Answer Questions That Matter to GLP-1 R&D

What GLP-1 R&D professionals are asking:

What excipients are most commonly used to stabilize GLP-1 analogs in oral delivery?

What formulations is Eli Lilly using to enhance the bioavailability of its GLP-1 receptor agonists?

Which co-formulation approaches are being patented for dual or triple agonists (GLP-1/GIP/glucagon)?

What methods have been used to protect GLP-1 from enzymatic degradation in GI conditions?

Which polymer systems from oncology delivery are being adapted for metabolic peptides?

Real Results from GLP-1 Industry Leaders

See how leading pharmaceutical companies are using Slate to solve complex R&D challenges and accelerate drug discovery process

“Slate helped us avoid a costly mistake. We could see the IP overlap in minutes and course-corrected in time. No other tool does this with such clarity.”

— VP of R&D Strategy

Results

Redirected IP filing strategy within 72 hours

Reprioritized R&D focus to unclaimed tri‑agonist innovation space

Avoided potential infringement risks by identifying overlapping claims

“Slate showed us a proven release tech from oncology weren’t even looking in. It gave us the confidence and data to push a novel GLP‑1 formulation into preclinical.”

— Head of Drug Delivery Research